Achilles Therapeutics plc
ACHL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$0 | -$12 | -$19 |
| Dep. & Amort. | – | $1 | $1 | $1 |
| Deferred Tax | – | $0 | $0 | -$4 |
| Stock-Based Comp. | – | $1 | $1 | $1 |
| Change in WC | – | -$0 | -$8 | $2 |
| Other Non-Cash | – | -$20 | $4 | $4 |
| Operating Cash Flow | – | -$0 | -$17 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | -$1 | -$0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$0 | $0 | $0 |
| Investing Cash Flow | – | -$0 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | -$0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $0 |
| Financing Cash Flow | – | $0 | $0 | -$0 |
| Forex Effect | – | $0 | -$1 | $6 |
| Net Chg. in Cash | – | -$17 | -$19 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $0 | $132 | $140 |
| End Cash | – | $0 | $112 | $132 |
| Free Cash Flow | – | -$0 | -$18 | -$14 |